Michelle Wolthuizen
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Pandemic Incident Management for Vaccine Safety Challenges: Victoria's Alert Advisory Group Experience.
Journal: Disaster medicine and public health preparedness
Published: September 03, 2024
Vaccine safety in Australia during the COVID-19 pandemic: Lessons learned on the frontline.
Journal: Frontiers in public health
Published: September 26, 2022
Victorian Specialist Immunisation Services (VicSIS) - bolstering adult clinics for COVID-19 vaccines.
Journal: Human vaccines & immunotherapeutics
Published: April 26, 2022
Reduction of body iron in HFE-related haemochromatosis and moderate iron overload (Mi-Iron): a multicentre, participant-blinded, randomised controlled trial.
Journal: The Lancet. Haematology
Published: September 07, 2017
Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron).
Journal: BMJ open
Published: August 14, 2015
Why do people choose not to have screening for hemochromatosis?
Journal: Genetic testing and molecular biomarkers
Published: October 27, 2012
To tell or not to tell - what to do about p.C282Y heterozygotes identified by HFE screening.
Journal: Clinical genetics
Published: August 28, 2012
ironXS: high-school screening for hereditary haemochromatosis is acceptable and feasible.
Journal: European journal of human genetics : EJHG
Published: January 12, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026